# Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients

> **NCT02390206** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 239 (actual)

## Conditions studied

- Spasticity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02390206
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-08-28
- **Final completion:** 2017-08-28
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2017-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390206, "Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02390206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*